FERRARI, ETTORE
 Distribuzione geografica
Continente #
NA - Nord America 691
EU - Europa 537
AS - Asia 345
OC - Oceania 2
SA - Sud America 1
Totale 1.576
Nazione #
US - Stati Uniti d'America 683
CN - Cina 338
IE - Irlanda 188
UA - Ucraina 90
FI - Finlandia 80
DE - Germania 47
SE - Svezia 44
GB - Regno Unito 30
IT - Italia 27
BE - Belgio 13
FR - Francia 11
CA - Canada 8
NL - Olanda 3
AU - Australia 2
ES - Italia 2
IL - Israele 2
SG - Singapore 2
TR - Turchia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
IR - Iran 1
RU - Federazione Russa 1
Totale 1.576
Città #
Dublin 188
Chandler 148
Jacksonville 102
Nanjing 85
Ann Arbor 58
Beijing 57
Nanchang 37
Ashburn 35
Helsinki 34
Wilmington 33
Changsha 31
Princeton 29
Lawrence 28
Medford 27
Hebei 25
Shenyang 25
Jiaxing 19
Woodbridge 19
Boardman 18
Piscataway 17
Hangzhou 16
Tianjin 15
Brussels 13
Shanghai 13
Fairfield 10
Verona 10
Toronto 8
Milan 7
Los Angeles 4
New York 4
Andover 3
Castronno 3
Des Moines 3
Falls Church 3
Jinan 3
Norwalk 3
Buffalo 2
Cambridge 2
Hadera 2
Istanbul 2
Kunming 2
Sacramento 2
Vitoria-Gasteiz 2
Auburn Hills 1
Bologna 1
Changchun 1
Falkenstein 1
Fuzhou 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Henderson 1
Lanzhou 1
Mozzanica 1
Ningbo 1
Novokuznetsk 1
Passo Fundo 1
Perth 1
Redwood City 1
Seattle 1
Singapore 1
Taizhou 1
Varese 1
Washington 1
Zhengzhou 1
Totale 1.170
Nome #
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease 96
Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging 93
Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. 89
Protein kinase C (PKC) beta II isoform activity in peripheral immune cells of type 2 diabetic patients with nephropathy 77
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly AD patients 74
Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging 71
Chrono-neuroendocrine markers of the aging brain. 65
Circadian neuroendocrine functions in disorders of eating behavior 63
Serum glucacon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity 62
Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia 56
Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia 55
Nutritional assessment of demented patients: a descriptive study 53
Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates 52
Cognitive and affective disorders in the elderly: a neuroendocrine study 51
Neuroendocrine features in extreme longevity 51
Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer’s disease: recovering effect with insulin and DHEA sulfate 51
INCREASED NATURAL KILLER CELL CYTOTOXICITY IN ALZHEIMER'S DISEASE MAY INVOLVE PROTEIN KINASE C DYSREGULATION 50
Vascular endotehelial growth factor (VEGF) defect in Alzheimer’s disease: recovering effect with insulin and Dhea-Sulfate. 49
Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus. 49
CORTISOL AND CYTOKINES MODULATORY EFFECTS ON CYTOLYTIC AND PROTEIN KINASE C ACTIVITIES OF NATURAL KILLER CELLS IN ALZHEIMER'S DISEASE. 47
Neurotransmitter and hormonal background of hostility in anorexia nervosa 47
Cytochemistry of circulating lymphocytes in diabetes mellitus with and without retinopathy and in newly diagnosed type I (insulin dependent) diabetes. 46
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients. Phase I ZANTE trial 45
Neuroendocrine correlates of the aging brain in humans 44
Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers 41
Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians 40
Evaluation of the circadian profiles of serum dehydroepiandrosterone (DHEA), cortisol, and cortisol/DHEA molar ratio after a single oral administration of DHEA in enderly subject 36
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer’s disease. 28
Changes in Endocrine Orcadian Rhythms as Markers of Physiological and Pathological Brain Aging 15
Totale 1.596
Categoria #
all - tutte 5.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020403 106 147 0 17 3 15 12 18 2 64 19 0
2020/2021189 26 16 6 16 2 28 2 28 8 25 24 8
2021/2022145 2 2 9 2 2 11 2 6 9 6 23 71
2022/2023479 48 43 5 34 46 40 2 24 216 4 14 3
2023/2024164 34 38 6 16 9 23 4 10 1 2 19 2
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.596